非小细胞肺癌的中西医结合治疗探讨  

Investigation of Combined Traditional Chinese and Western Medicine Treatment of Non- small Cell Lung Cancer

作　　者：郭园园[1] 王子川[1] 陈美娟[1] 

机构地区：[1]南京中医药大学基础医学院,江苏南京210023

出　　处：《中华中医药学刊》2015年第11期2697-2699,共3页Chinese Archives of Traditional Chinese Medicine

基　　金：江苏省自然科学基金项目(BK20131415);江苏高校优势学科建设工程项目;南京中医药大学基础医学院青年科技创新基金项目(14JCQN05)

摘　　要：西医治疗肺癌的主要手段在于手术、放化疗和分子靶向治疗。虽然技术不断革新,也不断出现新的分子靶向性药物,但该类治疗易于复发和转移,并且会不断产生抗药性。中医治疗肺癌倾向于扶正与祛邪并重,而且中医的"辨证施治"更能发挥"个体化治疗"的优势。将西医的早期诊断、靶向性治疗与中医的辨证论治、整体调理相结合,不仅有利于提高肺癌的临床疗效,改善病人的生活质量。另外,通过有效病例的积累,还将为探明肺癌的发生、发展机制提供宝贵的一手资料。由此必将推动肺癌的治疗从治疗手段的中西医结合到理论认识水平的中西医结合,从而使肺癌的临床治疗获得得更大的突破性进展。The main approaches of Western Medicine treatment of lung cancer is surgery,radiation,chemotherapy and molecular targeted therapy. Despite of the innovation of the technology and emergence of new targeted molecular drugs,recurrence,metastasis and resistance to the medicine are still the severe problems. Treatment of lung cancer through traditional Chinese medicine favorites strengthening healthy qi and eliminating pathogens. Furthermore,diagnosis and treatment based on an overall analysis of the illness and the patient＇s condition have the advantage of personality. Early diagnosis and targeted treatment by Western medicine combined with syndrome differentiation and whole regulation of traditional Chinese medicine is beneficial to improving the clinical curative effects and patient＇s quality of life. Moreover,an accumulation of effective cases will also provide valuable first- hand material for investigation of the occurrence and development mechanisms of lung cancer. This will be beneficial for promoting the combination of traditional Chinese medicine and Western medicine treatment theoretically and technically,and largely push the development of clinical treatment of lung cancer.

关 键 词：中西医结合 肺癌 非小细胞肺癌 

分 类 号：R734.2[医药卫生—肿瘤]